AB-Biotics SA (ABB)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:AB-Biotics SA (ABB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8010864
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月20日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AB-Biotics SA (AB-Biotics) is a provider of probiotics, specialty dietary supplements, pipeline products and other functional ingredients. The company’s products comprise probiotic products, iron-containing ingredients, lactobacillus plantarum, lactobacillus brevis, natural solutions, gastrointestinal treatment products and infantile colic products. Its other products comprise proprietary supplements, lysozyme and defensin peptides, pyloriosis, radiobal products, vitamin K products, neuropharmagen testing products, and probiosis products. AB-Biotics offers research and development, drug development, clinical testing services, financing, microbiology services, protocol development, and project execution services. The company markets its products in Spain and abroad. AB-Biotics is headquartered in Barcelona, Spain.

AB-Biotics SA (ABB) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AB-Biotics SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
AB-Biotics SA, Medical Devices Deals, 2011 to YTD 2017 9
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
AB-Biotics SA, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
AB-Biotics Enters into Distribution Agreement with Mylan 11
Ab-Biotics Enters into Distribution Agreement with Laboratorios Bago for Neurofarmagen 12
AB-Biotics Enters into Co-Development Agreement with Beijing E-Biotics 13
AB-Biotics Enters Into Co-Promotion Agreement With Scienta Farma For Neurofarmagen 14
AB-Biotics Enters Into Co-Promotion Agreement With GlaxoSmithKline For Neurofarmagen 15
Licensing Agreements 16
Ab-Biotics Enters into Option for Licensing Agreement with Wakamoto Pharma 16
AB-Biotics Enters into Licensing Agreement with Cilag 17
Equity Offering 18
AB-Biotics Raises USD5.4 Million in Public Offering of Shares 18
Asset Transactions 19
Frutarom Industries Acquires AB-Fortis Product from AB-Biotics 19
Acquisition 20
Ab-Biotics Acquires 10% Stakes in Access DX Laboratory 20
Almirall Acquires Stake In AB-Biotics, Biotechnology Company, For US$1.3 Million 21
AB-Biotics SA – Key Competitors 22
AB-Biotics SA – Key Employees 23
AB-Biotics SA – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
AB-Biotics SA, Pharmaceuticals & Healthcare, Key Facts, 2016 2
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AB-Biotics SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AB-Biotics SA, Deals By Therapy Area, 2011 to YTD 2017 8
AB-Biotics SA, Medical Devices Deals, 2011 to YTD 2017 9
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
AB-Biotics Enters into Distribution Agreement with Mylan 11
Ab-Biotics Enters into Distribution Agreement with Laboratorios Bago for Neurofarmagen 12
AB-Biotics Enters into Co-Development Agreement with Beijing E-Biotics 13
AB-Biotics Enters Into Co-Promotion Agreement With Scienta Farma For Neurofarmagen 14
AB-Biotics Enters Into Co-Promotion Agreement With GlaxoSmithKline For Neurofarmagen 15
Ab-Biotics Enters into Option for Licensing Agreement with Wakamoto Pharma 16
AB-Biotics Enters into Licensing Agreement with Cilag 17
AB-Biotics Raises USD5.4 Million in Public Offering of Shares 18
Frutarom Industries Acquires AB-Fortis Product from AB-Biotics 19
Ab-Biotics Acquires 10% Stakes in Access DX Laboratory 20
Almirall Acquires Stake In AB-Biotics, Biotechnology Company, For US$1.3 Million 21
AB-Biotics SA, Key Competitors 22
AB-Biotics SA, Key Employees 23
AB-Biotics SA, Other Locations 24

★海外企業調査レポート[AB-Biotics SA (ABB)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Laredo Petroleum Inc (LPI):企業の財務・戦略的SWOT分析
    Laredo Petroleum Inc (LPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Callaway Golf Company (ELY):企業の財務・戦略的SWOT分析
    Callaway Golf Company (ELY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • National Beverage Corp. (FIZZ):企業の財務・戦略的SWOT分析
    National Beverage Corp. (FIZZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Abeona Therapeutics Inc (ABEO)-医療機器分野:企業M&A・提携分析
    Summary Abeona Therapeutics Inc (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., is a biopharmaceutical company focusing on the development and delivery of gene therapy and plasma-based products for severe and life-threatening rare diseases. The company’s lead programs include ABO-101 and ABO …
  • Caris Life Sciences Inc:企業の製品パイプライン分析
    Summary Caris Life Sciences Inc (Caris Life) is a biotechnology company. The company’s molecular scientific offerings assess DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make personalized treatment decisions. Its ADAPT biotargeting system, is a plat …
  • Turquoise Hill Resources Ltd:企業の戦略・SWOT・財務情報
    Turquoise Hill Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Turquoise Hill Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • PQ Group Holdings, Inc (PQG):企業の財務・戦略的SWOT分析
    PQ Group Holdings, Inc (PQG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Ipsen Biopharmaceuticals Inc:企業の戦略的SWOT分析
    Ipsen Biopharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • RigNet Inc (RNET):石油・ガス:M&Aディール及び事業提携情報
    Summary RigNet Inc (RigNet) is a technology company that provides applications, customized communication services and cyber security solutions. Its managed services include remote communications and technology services for onshore and offshore drilling rigs, support vessels, production facilities, a …
  • Edgewell Personal Care LLC (EPC):企業の財務・戦略的SWOT分析
    Edgewell Personal Care LLC (EPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Yanzhou Coal Mining Co Ltd:企業のM&A・事業提携・投資動向
    Yanzhou Coal Mining Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Yanzhou Coal Mining Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Kala Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Kala Pharmaceuticals Inc (Kala Pharmaceuticals) is a clinical stage pharmaceutical company which focuses on nanoparticle-based treatments for ocular diseases affecting both front and back of the eye. The company’s lead program MPP nanosuspension of an ophthalmic corticosteroid is under phase …
  • Shuwen Biotech Co Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Shuwen Biotech Co Ltd (Shuwen Biotech) is a medical equipment company. The company develops diagnostic products and services for disease prevention, diagnosis and personalized medicine. It offers in-vitro diagnostic (IVD) kits for oncology and pregnancy-related conditions. Shuwen Biotech dev …
  • CardioDx Inc:企業の戦略的SWOT分析
    CardioDx Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Efora Energy Ltd (EEL):石油・ガス:M&Aディール及び事業提携情報
    Summary Efora Energy Ltd (Efora Energy), formerly SacOil Holdings Ltd, a subsidiary of Public Investment Corp Ltd, is an independent oil and gas exploration and production company that acquires, explores, develops and produces hydrocarbon assets in Africa. The company holds a diverse portfolio of as …
  • Leukocare AG:医療機器:M&Aディール及び事業提携情報
    Summary Leukocare AG (Leukocare) is a clinical-stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company’s services include development of spray drying and spray freeze-drying proce …
  • LyondellBasell Industries NV (LYB):企業の財務・戦略的SWOT分析
    LyondellBasell Industries NV (LYB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • China Petroleum & Chemical Corporation (Sinopec):戦略・SWOT・企業財務分析
    China Petroleum & Chemical Corporation (Sinopec) - Strategy, SWOT and Corporate Finance Report Summary China Petroleum & Chemical Corporation (Sinopec) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Zhejiang Xianju Pharmaceutical Co Ltd (002332):製薬・医療:M&Aディール及び事業提携情報
    Summary Zhejiang Xianju Pharmaceutical Co Ltd (Zhejiang Xianju Pharmaceutical) is a contract manufacturer of API and formulations. The company offers products such as ingredients, active pharmaceutical ingredients, steroids and hormones, pharmaceutical products, and finished formulations, among othe …
  • Sawai Pharmaceutical Co Ltd (4555):製薬・医療:M&Aディール及び事業提携情報
    Summary Sawai Pharmaceutical Co Ltd (Sawai Pharmaceutical) manufactures, sells, imports and exports ethical drugs and proprietary drugs. The company's products include cardiovascular drugs, antihyperlipidemic agents, diabetes drugs, anticancer drugs, and OTC drugs. It provides products in the form o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆